EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Major improvement in thyroid cancer survival of elderly patients in the Nordic countries

František Zitrický, Anni Koskinen, Vaclav Liska, Asta Försti, Akseli Hemminki iD, Kari Hemminki iD

European Journal of Endocrinology · 2024

DOI: 10.1093/ejendo/lvae015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von František Zitrický und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Center, Faculty of Medicine, Charles University Pilsen, Pilsen 30605, Czech Republic. Hauptthemen laut MEDLINE: Thyroid Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Union's Horizon 2020, Jane and Aatos Erkko Foundation, Sigrid Juselius Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

We describe age-specific survival in thyroid cancer (TC) from Denmark, Finland, Norway, and Sweden over a 50-year period.

Design

Population-based survival study.

Methods

Relative 5-year survival data were obtained from the NORDCAN database for the years 1972-2021.

Results

In the first period 1972-1976, 5-year survival in TC in Finland, Norway, and Sweden was 90% or higher, but a strong negative step-wise age gradient was observed, which was worse for men than women. Over time, survival increased, and in the final period, 2017-2021, survival for all women and Danish men up to age 69 years was about 90% or higher and, for men from the other countries, only marginally lower. Even for older women survival reached 80%, for older men somewhat less.

Conclusions

Age disadvantage in TC survival was for the most part corrected over the 50-year period, and the remaining task is to boost survival for the oldest patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsMaleHumansFemaleAgedSurvival RateRisk FactorsScandinavian and Nordic CountriesFinlandNorwaySwedenDenmarkIncidenceRegistriesAge Distribution

Stichwörter der Autor:innen

anaplastic cancermetastasisprognosisrelative survivaltrends

Autor:innen und Institutionen

  • Biomedical Center, Faculty of Medicine, Charles University Pilsen, Pilsen 30605, Czech Republic.
  • Department of Otorhinolaryngology- Head and Neck Surgery, Helsinki University Hospital, University of Helsinki, 00029 Helsinki, Finland.
  • Skin and Allergy Hospital, Helsinki University Hospital, University of Helsinki, 00029 Helsinki, Finland.
  • Biomedical Center, Charles University Medical School, 32300 Pilsen, Czech Republic.
  • Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany.
  • Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.

ORCID-Profile: Akseli Hemminki, Kari Hemminki

Förderung

  • European Union's Horizon 2020
  • Jane and Aatos Erkko Foundation
  • Sigrid Juselius Foundation
  • Finnish Cancer Organizations
  • University of Helsinki
  • Helsinki University Central Hospital
  • Novo Nordisk Foundation
  • Päivikki and Sakari Sohlberg Foundation

Zitieren

APA

Zitrický, F., Koskinen, A., Liska, V., Försti, A., Hemminki, A., & Hemminki, K. (2024). Major improvement in thyroid cancer survival of elderly patients in the Nordic countries. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae015

Vancouver

Zitrický F, Koskinen A, Liska V, Försti A, Hemminki A, Hemminki K. Major improvement in thyroid cancer survival of elderly patients in the Nordic countries. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae015

BibTeX
@article{Zitrick2024,
  author = {Zitrický, František and Koskinen, Anni and Liska, Vaclav and Försti, Asta and Hemminki, Akseli and Hemminki, Kari},
  title = {Major improvement in thyroid cancer survival of elderly patients in the Nordic countries},
  journal = {European Journal of Endocrinology},
  year = {2024},
  doi = {10.1093/ejendo/lvae015}
}
Kostenlos starten →